Demo Sign up Log In

Antares Pharma, Inc. (ATRS)

R&D Expenses

$16.87M

TTM · Period ending: Mar 31, 2022 · USD

ATRS R&D Expenses

Latest reported$16.87Mperiod endingMar 31, 2022

Latest reported$16.87Mperiod endingMar 31, 2022

ATRS R&D Expenses ($2.58M → $16.87M)

Annual R&D Expenses

High-resolution chart · PNG

ATRS r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. R&D Expenses — Annual fiscal periods (USD)
Period ending	R&D Expenses (USD)
Dec 31, 2021	14,502,000
Dec 31, 2020	10,121,000
Dec 31, 2019	10,624,000
Dec 31, 2018	12,328,000
Dec 31, 2017	13,147,000
Dec 31, 2016	21,126,936
Dec 31, 2015	19,731,564
Dec 31, 2014	18,638,016
Dec 31, 2013	15,263,371
Dec 31, 2012	14,921,552
Dec 31, 2011	6,699,325
Dec 31, 2010	8,802,502
Dec 31, 2009	7,902,486
Dec 31, 2008	7,866,499
Dec 31, 2007	5,362,291
Dec 31, 2006	3,778,469
Dec 31, 2005	3,409,486
Dec 31, 2004	3,546,438
Dec 31, 2003	3,493,966
Dec 31, 2002	3,654,333
Dec 31, 2001	3,555,874
Dec 31, 2000	1,223,034
Dec 31, 1999	2,417,779
Dec 31, 1998	3,516,856
Dec 31, 1997	2,573,814
Dec 31, 1996	2,584,806

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.